Deal Library / Pharma BD Deal Intelligence
The Pharma Closeout tracks 7 deals, $8.7B in disclosed deal value, 2 with a post-close Outcome Score for Genentech, Inc. (Roche Group).
Median Critic Score: 92 · Median Outcome Score: 69
Best outcome: Genentech, Inc. (Roche Group) / Tanox Inc. (80) · Weakest outcome: Genentech, Inc. (Roche Group) / Astex Pharmaceuticals (58)